Madawa W. Jayawardana - Publications

Spatial Profiling Reveals Immune Escape Pathways and Therapeutic Vulnerabilities in Prostate Cancer Bone Metastases.

Journal: Cancer research

Published: May 29, 2026

Using polygenic risk scores to refine risk and outcomes in high-grade serous ovarian cancer in Australia.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: December 07, 2025

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: Research square

Published: November 19, 2025

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: medRxiv : the preprint server for health sciences

Published: October 03, 2025

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: Nature communications

Published: September 22, 2025

Perioperative ctDNA as a prognostic biomarker in endometrial cancer - the CODEC study.

Journal: Translational oncology

Published: August 13, 2025

Perioperative ctDNA as a prognostic biomarker in endometrial cancer - the CODEC study.

Journal: Translational oncology

Published: August 13, 2025

Breast cancers arising in high mammographic density tissue harbor tumor-promoting immune profiles.

Journal: NPJ breast cancer

Published: February 10, 2025

Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression.

Journal: The Journal of pathology

Published: December 05, 2024

Predictive value of homologous recombination deficiency status for survival outcomes in primary tubo-ovarian high-grade serous carcinoma.

Journal: The Cochrane database of systematic reviews

Published: September 23, 2024

Feasibility and population exposure of 5-fluorouracil using therapeutic drug monitoring (PREDICT-5FU): A multicentre clinical trial.

Journal: British journal of clinical pharmacology

Published: July 03, 2024

Pharmacogenetic-guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1*28) chemotherapies for patients with cancer (PACIFIC-PGx): A multicenter clinical trial.

Journal: Clinical and translational science

Published: May 07, 2024